傳美財政部擬淡化投資中企股份禁令影響力 遭美國務院及國防部反對
《路透》引述消息報道,美國政府指令財政部就禁止美國投資者購買部分中國企業股份訂立指引,引發美國政府內部爭論。
2021年11月起,美國投資者將不能投資與中國軍方有關聯中國企業的證券,美國國防部至今列出35間企業與中國軍方有關,包括中海油(00883.HK)、中芯國際(00981.HK)等。
報道指國務院及國防部反對財政部發布的常見問題集內容。有消息稱財政部有意淡化指令的影響,但亦有消息指財政部的常見問題集指引將大致符合原來指令意旨。外界關注有關禁令會否牽連名單企業內的子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.